评估 2013 年至 2019 年期间美国商业保险癌症患者接受遗传咨询相关费用。
Evaluating Costs Associated With Genetic Counseling Among Commercially Insured US Patients With Cancer From 2013 to 2019.
机构信息
Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
出版信息
JAMA Health Forum. 2022 Jul 29;3(7):e222260. doi: 10.1001/jamahealthforum.2022.2260. eCollection 2022 Jul.
Abstract
This cohort study describes the prevalence of out-of-pocket costs for cancer-related genetic counseling services in the US.
摘要
本队列研究描述了美国癌症相关基因咨询服务自费费用的流行情况。
相似文献
1
Evaluating Costs Associated With Genetic Counseling Among Commercially Insured US Patients With Cancer From 2013 to 2019.评估 2013 年至 2019 年期间美国商业保险癌症患者接受遗传咨询相关费用。
JAMA Health Forum. 2022 Jul 29;3(7):e222260. doi: 10.1001/jamahealthforum.2022.2260. eCollection 2022 Jul.
2
Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.BRCA1和BRCA2乳腺癌易感基因突变的遗传咨询与检测费用。
Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):475-81.
3
Out-of-pocket costs for commercially insured patients with localized prostate cancer.商业保险患者前列腺癌局部治疗的自付费用。
Urol Oncol. 2021 Dec;39(12):797-805. doi: 10.1016/j.urolonc.2021.08.026. Epub 2021 Sep 30.
4
The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States.美国商业保险和医疗保险患者中肝肾综合征的负担。
Curr Med Res Opin. 2017 Aug;33(8):1473-1480. doi: 10.1080/03007995.2017.1331211. Epub 2017 Jun 2.
5
Polypharmacy, chemotherapy receipt, and medication-related out-of-pocket costs at end of life among commercially insured adults with advanced cancer.晚期癌症商业保险成年人的多病用药、化疗接受情况和临终时与药物相关的自费支出。
J Oncol Pharm Pract. 2022 Jun;28(4):836-841. doi: 10.1177/10781552211006180. Epub 2021 Apr 7.
6
Medical Service Use and Charges for Cancer Care in 2018 for Privately Insured Patients Younger Than 65 Years in the US.2018 年美国 65 岁以下私人保险患者癌症护理的医疗服务使用和费用。
JAMA Netw Open. 2021 Oct 1;4(10):e2127784. doi: 10.1001/jamanetworkopen.2021.27784.
7
Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.BRCA 基因检测和咨询在全国商业保险人群中的利用和结果：ABOUT 研究。
JAMA Oncol. 2015 Dec;1(9):1251-60. doi: 10.1001/jamaoncol.2015.3048.
8
Cost sharing, postpartum contraceptive use, and short interpregnancy interval rates among commercially insured women.商业保险女性的成本分担、产后避孕措施使用和短孕期间隔率。
Am J Obstet Gynecol. 2021 Mar;224(3):282.e1-282.e17. doi: 10.1016/j.ajog.2020.08.109. Epub 2020 Sep 6.
9
Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study.利用远程实时视频会议扩大社区医疗机构癌症基因检测服务的可及性：一项多中心可行性研究
J Med Internet Res. 2016 Feb 1;18(2):e23. doi: 10.2196/jmir.4564.
10
The prevalence of lower limb loss in children and associated costs of prosthetic devices: A national study of commercial insurance claims.儿童下肢缺失的患病率及假肢装置的相关成本：一项商业保险理赔的全国性研究。
Prosthet Orthot Int. 2021 Apr 1;45(2):115-122. doi: 10.1177/0309364620968645.
引用本文的文献
1
Cost-effectiveness of Lynch Syndrome Screening in Colorectal Cancer: Universal Germline vs Sequential Screening.林奇综合征在结直肠癌筛查中的成本效益：全人群种系筛查与序贯筛查
Clin Gastroenterol Hepatol. 2025 Apr 30. doi: 10.1016/j.cgh.2025.03.006.
2
Cost-Effectiveness of Remote Tailored Risk Communication and Navigation for Hereditary Genetic Risk Assessment Uptake: Economic Evaluation From the Genetic Risk Assessment for Cancer Education and Empowerment Trial.远程定制风险沟通与导航以促进遗传性基因风险评估接受度的成本效益：来自癌症教育与赋权基因风险评估试验的经济评估
JCO Oncol Pract. 2025 Jun;21(6):824-831. doi: 10.1200/OP-24-00617. Epub 2024 Dec 11.
3
Randomized trial promoting cancer genetic risk assessment when genetic counseling cost removed: 1-year follow-up.随机试验在去除遗传咨询费用后促进癌症遗传风险评估：1 年随访。
JNCI Cancer Spectr. 2024 Feb 29;8(2). doi: 10.1093/jncics/pkae018.
4
Prospective, multi-site study of healthcare utilization after actionable monogenic findings from clinical sequencing.从临床测序中获得有明确临床意义的单基因检测结果后的医疗保健利用的前瞻性、多中心研究。
Am J Hum Genet. 2023 Nov 2;110(11):1950-1958. doi: 10.1016/j.ajhg.2023.10.006. Epub 2023 Oct 25.
5
Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis.三种常见遗传性疾病的人群基因组筛查：成本效益分析
Ann Intern Med. 2023 May;176(5):585-595. doi: 10.7326/M22-0846. Epub 2023 May 9.
本文引用的文献
1
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.遗传/家族性高风险评估：乳腺癌、卵巢癌和胰腺癌，第 2.2021 版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001.
2
Positive impact of genetic counseling assistants on genetic counseling efficiency, patient volume, and cost in a cancer genetics clinic.遗传咨询师助理对癌症遗传学诊所的遗传咨询效率、患者量和成本的积极影响。
Genet Med. 2020 Aug;22(8):1348-1354. doi: 10.1038/s41436-020-0797-2. Epub 2020 Apr 30.
3
The past, present and future of service delivery in genetic counseling: Keeping up in the era of precision medicine.遗传咨询服务提供的过去、现在和未来：在精准医学时代与时俱进。
Am J Med Genet C Semin Med Genet. 2018 Mar;178(1):24-37. doi: 10.1002/ajmg.c.31602. Epub 2018 Mar 7.
4
Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.遗传性癌症风险评估、咨询与检测的基本要素：美国国家遗传咨询师协会的更新建议
J Genet Couns. 2012 Apr;21(2):151-61. doi: 10.1007/s10897-011-9462-x. Epub 2011 Dec 2.
5
Billing for medical genetics and genetic counseling services: a national survey.医学遗传学与遗传咨询服务计费：一项全国性调查。
J Genet Couns. 2010 Feb;19(1):38-43. doi: 10.1007/s10897-009-9249-5. Epub 2009 Oct 7.
Zotero 插件